About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Expert Opinion on Therapeutic Targets
›
top-articles
Expert Opinion on Therapeutic Targets
4.5
(top 10%)
impact factor
1.7K
(top 10%)
papers
75.2K
(top 5%)
citations
106
(top 5%)
h
-index
5.0
(top 10%)
extended IF
2.5K
all documents
80.9K
doc citations
150
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
795
2
Targeting the EGFR signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
718
3
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Expert Opinion on Therapeutic Targets
2012
591
4
Targeting selectins and selectin ligands in inflammation and cancer
Expert Opinion on Therapeutic Targets
2007
333
5
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Expert Opinion on Therapeutic Targets
2007
321
6
Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase
Expert Opinion on Therapeutic Targets
2012
302
7
Cathepsin B as a cancer target
Expert Opinion on Therapeutic Targets
2013
300
8
STAT proteins as novel targets for cancer drug discovery
Expert Opinion on Therapeutic Targets
2004
271
9
Targeting the dopamine D2receptor in schizophrenia
Expert Opinion on Therapeutic Targets
2006
268
10
The paraventricular nucleus of the hypothalamus – a potential target for integrative treatment of autonomic dysfunction
Expert Opinion on Therapeutic Targets
2008
262
11
Targeting CCL5 in inflammation
Expert Opinion on Therapeutic Targets
2013
258
12
MERS-CoV spike protein: a key target for antivirals
Expert Opinion on Therapeutic Targets
2017
244
13
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Expert Opinion on Therapeutic Targets
2018
236
14
Targeting the Bcl-2 family for cancer therapy
Expert Opinion on Therapeutic Targets
2013
221
15
From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer
Expert Opinion on Therapeutic Targets
2006
219
16
The 5-HT
3
receptor as a therapeutic target
Expert Opinion on Therapeutic Targets
2007
217
17
The potential of targeting Wnt/β-catenin in colon cancer
Expert Opinion on Therapeutic Targets
2014
205
18
Tyrosine kinases as targets in cancer therapy – successes and failures
Expert Opinion on Therapeutic Targets
2003
204
19
Targeting the HGF/Met signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
200
20
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Expert Opinion on Therapeutic Targets
2017
200
21
Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain
Expert Opinion on Therapeutic Targets
2017
199
22
Targeting TGF-β signaling in cancer
Expert Opinion on Therapeutic Targets
2013
188
23
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Expert Opinion on Therapeutic Targets
2019
188
24
Na
v
1.7 and other voltage-gated sodium channels as drug targets for pain relief
Expert Opinion on Therapeutic Targets
2016
181
25
Targeting acetylcholinesterase to treat neurodegeneration
Expert Opinion on Therapeutic Targets
2007
180
26
Targeting the PI3K signaling pathway in cancer therapy
Expert Opinion on Therapeutic Targets
2012
180
27
VEGF as a potential target in lung cancer
Expert Opinion on Therapeutic Targets
2017
177
28
CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects
Expert Opinion on Therapeutic Targets
2003
176
29
Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Expert Opinion on Therapeutic Targets
2012
170
30
Grb2 signaling in cell motility and cancer
Expert Opinion on Therapeutic Targets
2008
165
31
Targeting the ubiquitin–proteasome system for cancer therapy
Expert Opinion on Therapeutic Targets
2013
163
32
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review
Expert Opinion on Therapeutic Targets
2013
163
33
NF-κB as a therapeutic target in neurodegenerative diseases
Expert Opinion on Therapeutic Targets
2007
162
34
MUC16 as a novel target for cancer therapy
Expert Opinion on Therapeutic Targets
2018
157
35
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
Expert Opinion on Therapeutic Targets
2007
155
36
Targeting survivin in cancer therapy
Expert Opinion on Therapeutic Targets
2008
154
37
SIRT1: new avenues of discovery for disorders of oxidative stress
Expert Opinion on Therapeutic Targets
2012
150
38
TRAIL in cancer therapy: present and future challenges
Expert Opinion on Therapeutic Targets
2007
148
39
Development of ligand-targeted liposomes for cancer therapy
Expert Opinion on Therapeutic Targets
2004
147
40
The η-class carbonic anhydrases as drug targets for antimalarial agents
Expert Opinion on Therapeutic Targets
2015
147
41
Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?
Expert Opinion on Therapeutic Targets
2015
145
42
FOXP1: a potential therapeutic target in cancer
Expert Opinion on Therapeutic Targets
2007
144
43
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders
Expert Opinion on Therapeutic Targets
2019
144
44
Targeting IL-1 in depression
Expert Opinion on Therapeutic Targets
2012
142
45
Accelerating Medicines Partnership: Alzheimer’s Disease (AMP-AD) Knowledge Portal Aids Alzheimer’s Drug Discovery through Open Data Sharing
Expert Opinion on Therapeutic Targets
2016
142
46
Targeting disease through novel pathways of apoptosis and autophagy
Expert Opinion on Therapeutic Targets
2012
141
47
The aquaporin-4 water channel as a potential drug target in neurological disorders
Expert Opinion on Therapeutic Targets
2017
140
48
Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy
Expert Opinion on Therapeutic Targets
2005
138
49
The ERK/MAPK pathway, as a target for the treatment of neuropathic pain
Expert Opinion on Therapeutic Targets
2005
138
50
Disialoganglioside GD2 as a therapeutic target for human diseases
Expert Opinion on Therapeutic Targets
2015
136
site/software ©
exaly
; All materials licenced under
CC by-SA
.